These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21540093)

  • 21. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation.
    Aggarwal D; Garg A; Kaur IP
    J Pharm Pharmacol; 2004 Dec; 56(12):1509-17. PubMed ID: 15563757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementing Spanlastics for Improving the Ocular Delivery of Clotrimazole: In vitro Characterization, Ex vivo Permeability, Microbiological Assessment and In vivo Safety Study.
    Abdelbari MA; El-Mancy SS; Elshafeey AH; Abdelbary AA
    Int J Nanomedicine; 2021; 16():6249-6261. PubMed ID: 34531656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen.
    Elsayed MM; Abdallah OY; Naggar VF; Khalafallah NM
    Pharmazie; 2007 Feb; 62(2):133-7. PubMed ID: 17341034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatty alcohols or fatty acids as niosomal hybrid carrier: effect on vesicle size, encapsulation efficiency and in vitro dye release.
    Bandyopadhyay P; Johnson M
    Colloids Surf B Biointerfaces; 2007 Jul; 58(1):68-71. PubMed ID: 17339104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antifungal drug clotrimazole.
    Ning M; Gu Z; Pan H; Yu H; Xiao K
    Indian J Exp Biol; 2005 Feb; 43(2):150-7. PubMed ID: 15782815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sorbitan ester niosomes for topical delivery of rofecoxib.
    Das MK; Palei NN
    Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ionic liquid-in-oil microemulsion as a potential carrier of sparingly soluble drug: characterization and cytotoxicity evaluation.
    Moniruzzaman M; Tamura M; Tahara Y; Kamiya N; Goto M
    Int J Pharm; 2010 Nov; 400(1-2):243-50. PubMed ID: 20813174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semifluorinated alkanes as a liquid drug carrier system for topical ocular drug delivery.
    Dutescu RM; Panfil C; Merkel OM; Schrage N
    Eur J Pharm Biopharm; 2014 Sep; 88(1):123-8. PubMed ID: 24844949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of a drug delivery system to a steroidal ophthalmic preparation with lipid microspheres.
    Yanagawa A; Mizushima Y; Komatsu A; Horiuchi M; Shirasawa E; Igarashi R
    J Microencapsul; 1987; 4(4):329-31. PubMed ID: 3504514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
    Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin.
    Kuehne JJ; Yu AL; Holland GN; Ramaswamy A; Taban R; Mondino BJ; Yu F; Rayner SA; Giese MJ
    Am J Ophthalmol; 2004 Oct; 138(4):547-53. PubMed ID: 15488779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies.
    Abdelbary GA; Amin MM; Zakaria MY
    Drug Deliv; 2017 Nov; 24(1):309-319. PubMed ID: 28165809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
    Myles ME; Neumann DM; Hill JM
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole.
    Kakkar S; Karuppayil SM; Raut JS; Giansanti F; Papucci L; Schiavone N; Kaur IP
    Int J Pharm; 2015 Nov; 495(1):276-289. PubMed ID: 26325312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.
    Luo Q; Zhao J; Zhang X; Pan W
    Int J Pharm; 2011 Jan; 403(1-2):185-91. PubMed ID: 20951778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Amphotericin B--bioavailability in the cornea. Studies with local administration of liposome incorporated amphotericin B].
    Pleyer U; Grammer J; Pleyer JH; Kosmidis P; Friess D; Schmidt KH; Thiel HJ
    Ophthalmologe; 1995 Aug; 92(4):469-75. PubMed ID: 7549331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles.
    Contreras-Ruiz L; de la Fuente M; García-Vázquez C; Sáez V; Seijo B; Alonso MJ; Calonge M; Diebold Y
    Cornea; 2010 May; 29(5):550-8. PubMed ID: 20335805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of Microsporum canis--dermatophytosis.
    Aggarwal N; Goindi S
    Int J Pharm; 2012 Nov; 437(1-2):277-87. PubMed ID: 22939964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.
    Loftsson T; Hreinsdóttir D; Stefánsson E
    J Pharm Pharmacol; 2007 May; 59(5):629-35. PubMed ID: 17524227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.